News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,818 Results
Type
Article (5100)
Company Profile (17)
Press Release (218701)
Section
Business (82260)
Career Advice (463)
Deals (15046)
Drug Delivery (8)
Drug Development (19115)
Employer Resources (30)
FDA (3680)
Job Trends (3905)
News (120214)
Policy (7509)
Tag
Academia (304)
Alliances (14754)
Alzheimer's disease (238)
Approvals (3690)
Artificial intelligence (32)
Bankruptcy (96)
Best Places to Work (2867)
Breast cancer (42)
Cancer (366)
Career advice (393)
Cell therapy (87)
Clinical research (15929)
Collaboration (132)
Compensation (123)
COVID-19 (302)
C-suite (73)
Data (411)
Diabetes (32)
Diagnostics (2025)
Earnings (40264)
Employer resources (31)
Events (37456)
Executive appointments (246)
FDA (3870)
Funding (150)
Gene therapy (38)
GLP-1 (101)
Government (408)
Healthcare (5036)
Infectious disease (314)
Interviews (53)
IPO (7805)
Job creations (1122)
Job search strategy (362)
Layoffs (97)
Legal (2332)
Lung cancer (40)
Manufacturing (41)
Medical device (3843)
Medtech (3844)
Mergers & acquisitions (7399)
Metabolic disorders (100)
Neuroscience (310)
NextGen: Class of 2025 (1688)
Non-profit (736)
Northern California (744)
Obesity (47)
Opinion (30)
People (24448)
Phase I (4756)
Phase II (6933)
Phase III (5497)
Pipeline (352)
Postmarket research (628)
Preclinical (1859)
Press Release (66)
Prostate cancer (24)
Radiopharmaceuticals (105)
Rare diseases (60)
Real estate (1872)
Regulatory (5060)
Research institute (303)
Resumes & cover letters (68)
Southern California (552)
Startups (1010)
United States (5730)
Vaccines (29)
Date
Today (29)
Last 7 days (167)
Last 30 days (739)
Last 365 days (10662)
2025 (1289)
2024 (11038)
2023 (13203)
2022 (18677)
2021 (19702)
2020 (18258)
2019 (13237)
2018 (10233)
2017 (10022)
2016 (9182)
2015 (12149)
2014 (9601)
2013 (7714)
2012 (8340)
2011 (8812)
2010 (8646)
Location
Africa (186)
Arizona (52)
Asia (11391)
Australia (1591)
California (1548)
Canada (603)
China (48)
Colorado (66)
Connecticut (79)
Europe (24304)
Florida (204)
Georgia (28)
Illinois (100)
Indiana (50)
Japan (54)
Maine (37)
Maryland (181)
Massachusetts (1252)
Michigan (80)
Minnesota (121)
New Jersey (456)
New York (390)
North Carolina (283)
Northern California (744)
Ohio (46)
Pennsylvania (286)
South America (278)
Southern California (552)
Tennessee (26)
Texas (181)
Utah (47)
Virginia (31)
Washington State (139)
223,818 Results for "geron corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
Geron Corporation reported financial results and business highlights for the first quarter 2024.
May 2, 2024
·
13 min read
Press Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 19, 2025
February 19, 2025
·
2 min read
FDA
FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder
Approved for patients with low- to intermediate-risk myelodysplastic syndromes, Geron’s Rytelo is the first telomerase inhibitor to hit the market and the company’s first approved drug after 34 years in business.
June 7, 2024
·
2 min read
·
Kate Goodwin
Press Releases
Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
February 3, 2025
·
1 min read
Biotech Bay
Geron to Participate at Upcoming Investor Conferences in April 2024
Geron Corporation announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences.
April 3, 2024
·
1 min read
Press Releases
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
November 7, 2024
·
7 min read
Biotech Bay
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 20, 2024
Geron Corporation, a commercial stage biopharmaceutical company, reported that it has granted non-statutory stock options to purchase an aggregate of 222,660 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.
June 20, 2024
·
2 min read
Press Releases
Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 7, 2024
·
18 min read
Deals
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants.
March 19, 2024
·
4 min read
Press Releases
Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
November 12, 2024
·
9 min read
1 of 22,382
Next
